![PDF] Targeting FAK in human cancer: from finding to first clinical trials. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/26a9977be69e5b652809520c612c75a481f39781/2-Table1-1.png "PDF] Targeting FAK in human cancer: from finding to first clinical trials. | Semantic Scholar")
PDF] Targeting FAK in human cancer: from finding to first clinical trials. | Semantic Scholar
Focal adhesion kinase inhibitors, a heavy punch to cancer | SpringerLink
Molecules | Free Full-Text | Drug Discovery Targeting Focal Adhesion Kinase (FAK) as a Promising Cancer Therapy
FAK inhibitors with anti-tumor activity in preclinical studies and... | Download Scientific Diagram
Focal Adhesion Kinase (FAK) Inhibition Synergizes with KRAS G12C Inhibitors in Treating Cancer through the Regulation of the FAK–YAP Signaling - Zhang - 2021 - Advanced Science - Wiley Online Library
Targeting focal adhesion kinase in cancer cells and the tumor microenvironment | Experimental & Molecular Medicine
FAK Inhibition | FAK Inhibitor Review
Progress in the Development of Small Molecular Inhibitors of Focal Adhesion Kinase (FAK) | Journal of Medicinal Chemistry
Molecules | Free Full-Text | Drug Discovery Targeting Focal Adhesion Kinase (FAK) as a Promising Cancer Therapy
IJMS | Free Full-Text | The Crosstalk between FAK and Wnt Signaling Pathways in Cancer and Its Therapeutic Implication
Pharmacological FAK Inhibitors. | Download Table
PYK2/FAK inhibitors reverse hypoxia-induced drug resistance in multiple myeloma | Haematologica
Targeting FAK in anticancer combination therapies | Nature Reviews Cancer
Molecules | Free Full-Text | Drug Discovery Targeting Focal Adhesion Kinase (FAK) as a Promising Cancer Therapy
Focal Adhesion Kinase (FAK) Inhibition Synergizes with KRAS G12C Inhibitors in Treating Cancer through the Regulation of the FAK–YAP Signaling - Zhang - 2021 - Advanced Science - Wiley Online Library
Molecules | Free Full-Text | Drug Discovery Targeting Focal Adhesion Kinase (FAK) as a Promising Cancer Therapy
Targeting FAK in anticancer combination therapies | Nature Reviews Cancer
Targeting FAK in anticancer combination therapies | Nature Reviews Cancer
Targeting FAK in anticancer combination therapies | Nature Reviews Cancer
Design, Synthesis, and Biological Evaluation of 4-Arylamino Pyrimidine Derivatives as FAK Inhibitors and Tumor Radiotracers | Molecular Pharmaceutics
PF-562271 | ≥99%(HPLC) | Selleck | FAK inhibitor
Recent progress on FAK inhibitors with dual targeting capabilities for cancer treatment - ScienceDirect
Recent progress on FAK inhibitors with dual targeting capabilities for cancer treatment - ScienceDirect
Recent progress on FAK inhibitors with dual targeting capabilities for cancer treatment - ScienceDirect
Summary of clinical trials with FAK inhibitors. | Download Scientific Diagram
